Precigen, Inc. (NASDAQ: PGEN), a dynamic player in the biotechnology sector, is capturing investor attention with its pioneering gene and cell therapies. With a robust market capitalization of $1.28 billion,..
Stoke Therapeutics, Inc. (NASDAQ: STOK), a biotechnology company specializing in the development of treatments for severe genetic disorders, has been gaining attention in the healthcare sector. With the stock trading..
REGENXBIO Inc. (NASDAQ: RGNX) captures the attention of investors with its innovative gene therapy solutions and a significant potential upside. With a market capitalization of $650.51 million, this clinical-stage biotechnology..
For investors with an eye on the biotechnology sector, Cullinan Therapeutics, Inc. (NASDAQ: CGEM) presents a compelling opportunity. This clinical-stage biopharmaceutical company, headquartered in Cambridge, Massachusetts, is pioneering therapies for..
Bicycle Therapeutics plc (NASDAQ: BCYC) stands out in the biotechnology sector with its innovative approach to developing therapeutics for diseases underserved by current treatments. Based in the United Kingdom, this..
Intellia Therapeutics, Inc. (NTLA), a trailblazer in the field of gene editing, is capturing investor attention with a remarkable potential upside of 134.89%. This biotechnology company is at the forefront..
SIGA Technologies Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company headquartered in New York, focuses primarily on the health security market in the United States. Known for its lead product, TPOXX,..
AxoGen, Inc. (AXGN), a key player in the medical devices sector, continues to capture investor attention with its innovative approach to peripheral nerve regeneration and repair. Headquartered in Alachua, Florida,..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is making waves in the biotechnology sector with its focus on developing groundbreaking gene therapies for rare and life-threatening diseases. With a market capitalization of..
RxSight, Inc. (NASDAQ: RXST), a promising player in the healthcare sector, specifically in the medical devices industry, has been making waves with its cutting-edge technology in cataract surgery. Headquartered in..
Maze Therapeutics, Inc. (NASDAQ: MAZE), a dynamic player in the biotechnology sector, is capturing investor attention with its promising pipeline of precision medicines. Based in South San Francisco, California, Maze..
Cel-Sci Corporation (NASDAQ: CVM) is a clinical-stage biotechnology firm that has captured the attention of investors with its ambitious approach to leveraging the immune system in the fight against cancer..
Taysha Gene Therapies, Inc. (TSHA), a pioneering name in the biotechnology industry, commands attention with its potential upside of 83.53%, making it a compelling consideration for investors keen on the..
Owens & Minor, Inc. (NYSE: OMI), with its rich history dating back to 1882, operates at the heart of the healthcare sector, specifically within the medical distribution industry. Headquartered in..
Community Health Systems, Inc. (NYSE: CYH) is positioned in a dynamic segment of the healthcare sector—medical care facilities—making it a notable consideration for investors focused on this industry. The company,..
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a pioneering force in the biotechnology sector, is making waves with its promising outlook in the treatment of brain health disorders. Headquartered in New..
For investors keeping a keen eye on the healthcare information services sector, Definitive Healthcare Corp. (NASDAQ: DH) offers an intriguing proposition. The company, based in Framingham, Massachusetts, operates a software..
Semler Scientific, Inc. (NASDAQ: SMLR), a dynamic player in the healthcare sector, specializes in medical devices designed to enhance clinical efficiency. Notably, its flagship product, QuantaFlo, offers an innovative edge..
Immatics N.V. (NASDAQ: IMTX), a Germany-based biotechnology firm, stands out in the healthcare sector with a promising focus on pioneering T cell redirecting immunotherapies aimed at combating cancer. With a..
In the ever-evolving healthcare landscape, Keros Therapeutics, Inc. (NASDAQ: KROS) has emerged as a compelling player within the biotechnology sector. With its focus on novel therapeutics aimed at treating disorders..
